About AGENTIX CORP Company

Agentix Corp.is a biotechnology company, which engages in the provision of development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease and ischemic reperfusion injury. It is focused on the development of synthetic agonists, inverse agonists and antagonists which modulate the endocannabinoid system (ECS). The ECS is a network of G-protein coupled receptors (GPCRs) that help regulate a variety of metabolic and neurotransmission functions. The company was founded on April 18, 2013 and is headquartered in Dana Point, CA.